The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 760K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for A Naganawa


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
19
Discovery of novel S1P2 antagonists, part 3: Improving the oral bioavailability of a series of 1,3-bis(aryloxy)benzene derivatives.EBI
Ono Pharmaceutical
14
Discovery of novel S1P2 antagonists. Part 2: Improving the profile of a series of 1,3-bis(aryloxy)benzene derivatives.EBI
Ono Pharmaceutical
25
Discovery of novel S1P2 antagonists. Part 1: discovery of 1,3-bis(aryloxy)benzene derivatives.EBI
Ono Pharmaceutical
31
Discovery of new orally active prostaglandin D2 receptor antagonists.EBI
Ono Pharmaceutical
26
Design, synthesis, and biological evaluation of novel somatostatin receptor subtype-2 agonists: Optimization for potency and risk mitigation of hERG and phospholipidosis.EBI
Ono Pharmaceutical
17
Design and synthesis of a highly selective EP2-receptor agonist.EBI
Minase Research Institute
13
Synthesis and evaluation of a potent, well-balanced EPEBI
Ono Pharmaceutical
15
Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain.BDB
The Scripps Research Institute